{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:28:19Z","timestamp":1788366499116,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The aim of this study included determining the prevalence of hypothyroidism in patients with systemic lupus erythematosus (SLE), clarifying the clinical characteristics of SLE patients with hypothyroidism, and identifying the relationship between hypothyroidism and SLE-related organic damage. Another purpose was to analyze the relationship between SLE and thyroid autoantibody. We also intended to discuss the pathogenesis of hypothyroidism in SLE patients, which would provide clues for further investigation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study recruited 856 SLE patients and 856 age- and sex-matched healthy population and compared the prevalence of hypothyroidism between the cases and controls. Univariate and multivariate logistic analyses were applied to identify risk factors for hypothyroidism in SLE patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>SLE patients had higher prevalence of clinical hypothyroidism (9.10%) and TgAb+TPOAb- (10.40%) than controls. The prevalence of hypothyroidism was the highest in SLE patients aged 16-26 years (18.9%) and decreased with age. The prevalence of autoimmune hypothyroidism in SLE group was higher than that in the control group (64.4% vs. 51.5%, <jats:italic>P<\/jats:italic>=0.042), which was mainly due to TgAb; the prevalence of non-autoimmune hypothyroidism in SLE group was also significantly higher than that in the control group (67.3% vs. 47.8%, <jats:italic>P<\/jats:italic>&amp;lt;0.001). Based on multivariate analysis, the use of glucocorticoids\/immunosuppressants, liver abnormality, lupus nephritis (LN), and cardiac insufficiency were independently associated with hypothyroidism in SLE patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The prevalence of hypothyroidism in SLE patients was higher than that in controls and decreased with age. The results suggested that young SLE patients combined with LN, liver abnormality and cardiac insufficiency were at higher risk of hypothyroidism. According to the results of this study, we speculated that SLE might have impact on thyroid, and SLE might be one of the causes of hypothyroidism.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.920283","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T08:23:13Z","timestamp":1657873393000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Systemic Lupus Erythematosus Patients With Related Organic Damage Are at High Risk of Hypothyroidism"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiajia","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38239","article-title":"The Incidence and Prevalence of Systemic Lupus Erythematosus, 2002-2004: The Georgia Lupus Registry","volume":"66","author":"Lim","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/art.38238","article-title":"Population-Based Incidence and Prevalence of Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program","volume":"66","author":"Somers","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/03009740802419073","article-title":"Occurrence of Systemic Lupus Erythematosus in a Danish Community: An 8-Year Prospective Study","volume":"38","author":"Laustrup","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206334","article-title":"The Incidence and Prevalence of Systemic Lupus Erythematosus in the UK, 1999-2012","volume":"75","author":"Rees","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318789788","article-title":"Mortality and Prognostic Factors in Chinese Patients With Systemic Lupus Erythematosus","volume":"27","author":"Mu","year":"2018","journal-title":"Lupus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22173","article-title":"Overall and Cause-Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta-Analysis of Observational Studies","volume":"66","author":"Yurkovich","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0067","article-title":"Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence From 31 Provinces of Mainland China","volume":"30","author":"Li","year":"2020","journal-title":"Thyroid"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.3.4.623","article-title":"The Kaleidoscope of Autoimmunity: Multiple Autoimmune Syndromes and Familial Autoimmunity","volume":"3","author":"Anaya","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11105","article-title":"Thyroid Disease in Lupus: An Updated Review","volume":"2","author":"Klionsky","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"B11","article-title":"Subclinical Hypothyroidism is a Risk Factor for Delayed Clinical Complete Response in Patients With Systemic Lupus Erythematosus (SLE)","volume":"7","author":"Dong","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311401456","article-title":"Subclinical Hypothyroidism and its Association With Lupus Nephritis: A Case Control Study in a Large Cohort of Chinese Systemic Lupus Erythematosus Patients","volume":"20","author":"Gao","year":"2011","journal-title":"Lupus"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and Validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F;20:","article-title":"The American College of Rheumatology Nomenclature and Case Definitions for Neuropsychiatric Lupus Syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2020.08.026","article-title":"Hypothyroidism and its Association With Systemic Lupus Erythematosus: A Cross Sectional Study in Chinese Patients","volume":"361","author":"Li","year":"2021","journal-title":"Am J Med Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2016.11.008","article-title":"Systemic Lupus Erythematosus and Thyroid Disease - Experience in a Single Medical Center in Taiwan","volume":"52","author":"Liu","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12662","article-title":"Autoimmune Thyroid Disease in Colombian Patients With Systemic Lupus Erythematosus","volume":"83","author":"Franco","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.metabol.2009.10.010","article-title":"Prevalence of Thyroid Dysfunctions in Systemic Lupus Erythematosus","volume":"59","author":"Antonelli","year":"2010","journal-title":"Metabolism"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.77.5.8077303","article-title":"Complex Alteration of Thyroid Function in Healthy Centenarians","volume":"77","author":"Mariotti","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid Autoimmunity: Role of Anti-Thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases","volume":"8","author":"Fr\u00f6hlich","year":"2017","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000501033","article-title":"Moderate Frequency of Anti-Thyroglobulin Antibodies in the Early Phase of Subacute Thyroiditis","volume":"8","author":"Nishihara","year":"2019","journal-title":"Eur Thyroid J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0975","article-title":"Effect of the Transition From More Than Adequate Iodine to Adequate Iodine on National Changes in the Prevalence of Thyroid Disorders: Repeat National Cross-Sectional Surveys in China","volume":"186","author":"Li","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0898","article-title":"Genomic and Nongenomic Effects of Glucocorticoids","volume":"4","author":"Stahn","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12364","article-title":"Unraveling the Functions of the Membrane-Bound Glucocorticoid Receptors: First Clues on Origin and Functional Activity","volume":"1318","author":"Strehl","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00169.x","article-title":"Increased Prevalence of Subclinical and Clinical Hypothyroidism in Persons With Chronic Kidney Disease","volume":"67","author":"Lo","year":"2005","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/edrv-17-1-45","article-title":"Thyroid Hormone Metabolism and Thyroid Diseases in Chronic Renal Failure","volume":"17","author":"Kaptein","year":"1996","journal-title":"Endocr Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050594","article-title":"Bilateral Nephrectomy Reverses Hypothyroidism in Congenital Nephrotic Syndrome","volume":"13","author":"Chadha","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"B29","article-title":"Liver Involvement in Systemic Lupus Erythematosus: Incidence, Clinical Course and Outcome of Lupus Hepatitis","volume":"28","author":"Piga","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"B30","article-title":"Clinical and Immunopathological Features of Patients With Lupus Hepatitis","volume":"126","author":"Zheng","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320923398","article-title":"Hepatic Manifestations in Systemic Lupus Erythematosus","volume":"29","author":"Gonz\u00e1lez-Regueiro","year":"2020","journal-title":"Lupus"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2532","article-title":"Update in Lipid Alterations in Subclinical Hypothyroidism","volume":"97","author":"Pearce","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-017-9830-1","article-title":"Primary Biliary Cholangitis: A Comprehensive Overview","volume":"11","author":"Lleo","year":"2017","journal-title":"Hepatol Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.5.1.112","article-title":"Hypothyroidism as a Cause of Hypertension","volume":"5","author":"Saito","year":"1983","journal-title":"Hypertension"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1002091","article-title":"Blood Pressure in Relation to Serum Thyrotropin: The Troms\u00f8 Study","volume":"20","author":"Iqbal","year":"2006","journal-title":"J Hum Hypertens"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3747\/co.23.3026","article-title":"Thyroid Hormone Autoantibodies: Are They a Better Marker to Detect Early Thyroid Damage in Patients With Hematologic Cancers Receiving Tyrosine Kinase Inhibitor or Immunoregulatory Drug Treatments","volume":"23","author":"Mondello","year":"2016","journal-title":"Curr Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/13.5.675","article-title":"Effective Antigen Presentation by Dendritic Cells is NF-kappaB Dependent: Coordinate Regulation of MHC, Co-Stimulatory Molecules and Cytokines","volume":"13","author":"Yoshimura","year":"2001","journal-title":"Int Immunol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.920283\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T08:23:18Z","timestamp":1657873398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.920283\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":37,"alternative-id":["10.3389\/fendo.2022.920283"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.920283","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"article-number":"920283"}}